Ascendia Pharma

Benefits of nanotechnologies in supporting formulation development of poorly soluble molecules.

Optimizing Drug Delivery Methods With Nanotechnologies

Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, discusses:

Capabilities related to formulation development and manufacturing of cGMP batches

Considerations in the development of formulations for poorly soluble molecules

Role of nanotechnologies to optimize drug delivery methods, such as long-acting injectables

Videos

Shaukat Ali, PhD, Senior Director of Scientific Affairs and Technical Marketing, Ascendia Pharmaceuticals, highlights the benefits of the company’s nanotechnologies in supporting formulation development of poorly soluble molecules.

Traits that a (bio)pharmaceutical company should look for when identifying a CDMO to support drug development and manufacturing programs.

Identifying the Right CDMO to Support Biopharma Manufacturing

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals discusses:

What to look for when identifying a CDMO for a drug development project

Ascendia Pharmaceuticals and its expansion of manufacturing services

Ascendia Pharmaceuticals as a "Partner of Choice" 

Robert Bloder, Chief Business Officer, Ascendia Pharmaceuticals, highlights traits that a (bio)pharmaceutical company look for when identifying a CDMO to support drug development and manufacturing programs.

New opportunities in formulation development that support biopharmaceutical development.

New Opportunities via Novel Formulation Technologies

Jim Huang, CEO of Ascendia Pharmaceuticals discusses:

Ascendia Pharmaceuticals growth and culture

Recent advances including the company's fourth nanotechnology – LipidSol

Ascendia Pharmaceuticals CEO, Jim Huang, describes how new opportunities in formulation development complement the company’s previous work in developing novel nanotechnologies to support biopharmaceutical development.

Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules

Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing

Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them

Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical 

What does Ascendia do?

What sets Ascendia apart from its competitors?

What is Ascendia's company culture like?

Meet Ascendia Pharmaceuticals

Articles

This white paper from Ascendia Pharma details four factors to consider when selecting a CDMO for your next drug development project. 